Literature DB >> 8399900

Ureaplasma urealyticum and chronic lung disease of prematurity: critical appraisal of the literature on causation.

E E Wang1, G H Cassell, P J Sánchez, J A Regan, N R Payne, P P Liu.   

Abstract

A critical appraisal of four cohort studies examining the relationship between Ureaplasma urealyticum and chronic lung disease (CLD) of prematurity is presented. Three studies were concurrently conducted, but the fourth was conducted 4 years later when surfactant replacement was a widespread practice. Although infants were enrolled in all studies soon after birth before they had developed CLD, there were differences in patients population, the definition of colonization with U. urealyticum, neonatal management, and the definition of CLD of prematurity. Despite the differences, all four studies found an association between colonization and development of CLD of prematurity. A combined estimate of relative risk for the four studies was 1.91 (95% confidence interval, 1.54-2.37). When infants were categorized into groups by birth weight, the association was not observed in infants who weighed > 1,250 g. The association was also not observed in infants who weighed < 750 g, but the risk of CLD of prematurity in the uncolonized control group was already 82%. Because the cohort study design allows for the possibility that one or more additional factors associated with U. urealyticum may be the true cause(s) of CLD of prematurity, there is strong but not definitive evidence that U. urealyticum causes CLD of prematurity.

Entities:  

Mesh:

Year:  1993        PMID: 8399900     DOI: 10.1093/clinids/17.supplement_1.s112

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

1.  Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents.

Authors:  A Matlow; C Th'ng; D Kovach; P Quinn; M Dunn; E Wang
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

2.  Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates.

Authors:  Katherine Pandelidis; Amanda McCarthy; Kirsty L Chesko; Rose M Viscardi
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

Review 3.  Chorioamnionitis: Is a major player in the development of bronchopulmonary dysplasia?

Authors:  Chang Won Choi
Journal:  Korean J Pediatr       Date:  2017-07-31

4.  Randomised trial of azithromycin to eradicate Ureaplasma in preterm infants.

Authors:  Rose Marie Viscardi; Michael L Terrin; Laurence S Magder; Natalie L Davis; Susan J Dulkerian; Ken B Waites; Namasivayam Ambalavanan; David A Kaufman; Pamela Donohue; Deborah J Tuttle; Jorn-Hendrik Weitkamp; Hazem E Hassan; Natalie D Eddington
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2020-03-13       Impact factor: 5.747

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.